PCSK9 vaccine

The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogeni...

Full description

Saved in:
Bibliographic Details
Main Authors Wyatt, David Michael, Ullah, Jakir Hussain, Champion, Jr., Brian Robert, Contillo, Jr., Leonard Gabriel, Qiu, Xiayang, Pierce, Brian Gregory, Fraser, James Downey, Eisenbraun, Michael Dale, Hawkins, Julie Jia Li, Merson, James Richard
Format Patent
LanguageEnglish
Published 05.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
Bibliography:Application Number: US201615266812